Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Novel Model for Headache Medicine Education
Headache
P11 - Poster Session 11 (5:30 PM-6:30 PM)
12-006

Headache disorders affect 12% of the US population and rank globally as the second most disabling medical condition; despite this, headache disorders are commonly misdiagnosed or mismanaged. One identified cause is inadequate provider training. To address this gap, the Jefferson Headache Center and the College of Nursing at Thomas Jefferson University created the Advanced Headache Diagnosis & Management Program. This comprehensive 1-year curriculum and mentorship program specifically applied to providers who were already practicing clinically and/or who were not eligible to complete a Headache Medicine fellowship. The goal of this education model is to increase the number of providers across multiple disciplines who can effectively diagnose and treat headache disorders. 

We describe a model for delivering comprehensive headache medicine education to practicing clinical providers across multiple disciplines. Key demographic features of providers enrolled in the program are discussed.

The Advanced Headache Diagnosis & Management Program offered didactic coursework on clinical diagnosis, pathogenesis, pharmacological and non-pharmacological treatments, psychiatric and sleep disorders, and business management. Content was presented through asynchronous interactive modules and discussion boards, and synchronous webinars. An onsite intensive provided in-person student interaction with mentors, clinical practice, and feedback.  

Since its initiation, the program has enrolled 55 providers over four cohorts. Provider types include physicians (34.55%), nurse practitioners (50.91%), physician assistants (7.27%), psychologists (3.64%), and nurse anesthetists (3.64%). Primary specialties include adult neurology (52.73%), pediatric neurology (3.64%), headache medicine (16.36%), pain (7.27%), family medicine (5.45%), emergency medicine (3.64%), psychology (3.64%), oral and maxillofacial surgery (1.82%), internal medicine (1.82%), and PM&R (1.82%). Special provider practice settings include: international/non-US based (9.09%), Veterans Health Administration (12.73%), and the Indian Health Service (1.82%).

This program is a unique model for delivering comprehensive, interactive content and access to quality headache medicine education and mentorship to a diverse group of clinicians worldwide.

Authors/Disclosures
Simy K. Parikh, MD (Jefferson Hospital For Neuroscience Headache Center)
PRESENTER
Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parikh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Author with Medlink. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Touch Independent Medical Education (touchIME) . Dr. Parikh has a non-compensated relationship as a Medical Advisory Board Member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities.
William B. Young, MD, FAAN (Jefferson Headache Center) Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Stephen D. Silberstein, MD, FAAN (Jefferson Headache Center) Dr. Silberstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Silberstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alergan. Dr. Silberstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Silberstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Silberstein has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Davies McFarland & Carroll, LLC. Dr. Silberstein has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for SHEEHEY FURLONG & BEHM P.C.. The institution of Dr. Silberstein has received research support from Lundbeck. The institution of Dr. Silberstein has received research support from abbvie. The institution of Dr. Silberstein has received research support from lundbeck. Dr. Silberstein has received publishing royalties from a publication relating to health care.
Hannah Smith, PhD (Thomas Jefferson University Jefferson School of Nursing - Philadelphia, PA) The institution of Dr. Smith has received research support from Abbvie.